183 related articles for article (PubMed ID: 20606411)
1. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
[TBL] [Abstract][Full Text] [Related]
2. Aplastic anemia and concomitant autoimmune diseases.
Stalder MP; Rovó A; Halter J; Heim D; Silzle T; Passweg J; Rischewski J; Stern M; Arber C; Buser A; Meyer-Monard S; Tichelli A; Gratwohl A
Ann Hematol; 2009 Jul; 88(7):659-65. PubMed ID: 19139895
[TBL] [Abstract][Full Text] [Related]
3. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO).
Jeong DC; Chung NG; Kang HJ; Koo HH; Kook H; Kim SK; Kim SY; Kim HS; Kim HM; Park KD; Park SK; Park JS; Park JE; Park HJ; Park YS; Seo JJ; Sung KW; Shin HY; Ahn HS; Ryu KH; Ryu KH; Yoo ES; Lyu CJ; Lee KS; Lee KC; Lee SY; Lee YH; Lim YT; Lim YJ; Jung HL; Cho B; Choi YM; Hah JO; Hwang TJ; Kim HK
J Pediatr Hematol Oncol; 2011 Apr; 33(3):172-8. PubMed ID: 21325968
[TBL] [Abstract][Full Text] [Related]
5. Danazol as first-line therapy for aplastic anemia.
Jaime-Pérez JC; Colunga-Pedraza PR; Gómez-Ramírez CD; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Tarín-Arzaga LC; Gómez-Almaguer D
Ann Hematol; 2011 May; 90(5):523-7. PubMed ID: 21279356
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.
George B; Mathews V; Viswabandya A; Lakshmi KM; Srivastava A; Chandy M
Pediatr Hematol Oncol; 2010 Mar; 27(2):122-31. PubMed ID: 20201693
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.
Piccin A; McCann S; Socié G; Oneto R; Bacigalupo A; Locasciulli A; Marsh J; Schrezenmeier H; Tichelli A; Hand E; Lawler M; Passweg J;
Bone Marrow Transplant; 2010 Jun; 45(6):1008-13. PubMed ID: 19915627
[TBL] [Abstract][Full Text] [Related]
8. [A long-term follow-up study of 50 patients with severe aplastic anemia who have survived more than 3 years after immunosuppressive therapy].
He G; Shao Z; Liu H; Zhang Y; Chen G; Li K; Song L; He H; Zhao M; Fu R; Shi J; Bai J; Zhang H; Chu Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):229-32. PubMed ID: 12133441
[TBL] [Abstract][Full Text] [Related]
9. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
11. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
[TBL] [Abstract][Full Text] [Related]
12. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
14. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party.
Locasciulli A; Bacigalupo A; Bruno B; Montante B; Marsh J; Tichelli A; Socié G; Passweg J;
Br J Haematol; 2010 Jun; 149(6):890-5. PubMed ID: 20456352
[TBL] [Abstract][Full Text] [Related]
16. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
Fang JP; Xu HG; Huang SL; Chen C; Huang K
Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
[TBL] [Abstract][Full Text] [Related]
18. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.
Hinterberger W; Hinterberger-Fischer M; Marmont A
Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia].
Zhai WH; Wang M; Zhou Z; Zhai WJ; Zhang RL; Wang H; Song AX; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):78-82. PubMed ID: 17650665
[TBL] [Abstract][Full Text] [Related]
20. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]